IRIS
ARNALDI, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.817
EU - Europa 3.097
AS - Asia 2.372
SA - Sud America 886
AF - Africa 100
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.282
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.750
SG - Singapore 921
BR - Brasile 746
CN - Cina 526
UA - Ucraina 522
IT - Italia 450
RU - Federazione Russa 425
IE - Irlanda 419
SE - Svezia 332
DE - Germania 293
HK - Hong Kong 274
VN - Vietnam 265
GB - Regno Unito 177
DK - Danimarca 143
TR - Turchia 120
FI - Finlandia 110
FR - Francia 93
KR - Corea 73
AR - Argentina 55
CI - Costa d'Avorio 49
IN - India 47
CA - Canada 33
BE - Belgio 30
BD - Bangladesh 26
NL - Olanda 25
EC - Ecuador 23
MX - Messico 23
ID - Indonesia 20
PL - Polonia 19
CO - Colombia 17
MA - Marocco 17
ZA - Sudafrica 16
JP - Giappone 15
VE - Venezuela 15
ES - Italia 14
IQ - Iraq 14
LT - Lituania 12
PY - Paraguay 12
IR - Iran 11
UZ - Uzbekistan 9
AT - Austria 8
CZ - Repubblica Ceca 8
PK - Pakistan 8
AE - Emirati Arabi Uniti 7
EG - Egitto 6
RO - Romania 6
SA - Arabia Saudita 6
UY - Uruguay 6
CL - Cile 5
PE - Perù 5
AU - Australia 4
EU - Europa 4
HN - Honduras 4
JM - Giamaica 4
NP - Nepal 4
TN - Tunisia 4
AM - Armenia 3
BG - Bulgaria 3
DZ - Algeria 3
JO - Giordania 3
LB - Libano 3
PS - Palestinian Territory 3
AZ - Azerbaigian 2
BO - Bolivia 2
BW - Botswana 2
KE - Kenya 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
TH - Thailandia 2
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
ML - Mali 1
MY - Malesia 1
NO - Norvegia 1
QA - Qatar 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
Totale 13.282
Salva come PNG Salva come JPEG
Città #
Chandler 677
Jacksonville 673
Ashburn 640
Singapore 579
Des Moines 457
Fairfield 425
Dublin 418
Dallas 387
Boardman 359
Hong Kong 274
New York 222
Wilmington 220
Woodbridge 191
Seattle 177
Ann Arbor 162
Lawrence 161
Princeton 161
San Mateo 151
Houston 141
Cambridge 128
Beijing 107
Moscow 99
Los Angeles 97
The Dalles 96
Centro 93
Ho Chi Minh City 91
São Paulo 82
Hefei 62
Hanoi 60
San Diego 55
Abidjan 49
Turin 38
London 34
Helsinki 32
Chicago 31
Buffalo 30
Shanghai 30
Brussels 28
Munich 28
Council Bluffs 27
Rio de Janeiro 25
Washington 25
Guangzhou 23
Norwalk 21
Pune 19
Denver 18
Rome 18
Santa Clara 18
Brooklyn 17
Montreal 17
Civitanova Marche 16
Tokyo 15
Belo Horizonte 14
Brasília 14
Columbus 14
Porto Alegre 14
Wuhan 14
New Bedfont 13
Warsaw 13
Ancona 12
Ribeirão Preto 12
Stockholm 12
Turku 12
Biên Hòa 11
Boston 11
Curitiba 11
Fortaleza 11
Nuremberg 11
Wuxi 11
Atlanta 10
Da Nang 10
Falls Church 10
Frankfurt am Main 10
Guayaquil 10
Kilburn 10
Phoenix 10
Salvador 10
San Francisco 10
Ascoli Piceno 9
Buenos Aires 9
Jinhua 9
Orem 9
Pescara 9
Redmond 9
Tashkent 9
Yiwu 9
Ankara 8
Caxias do Sul 8
Manchester 8
Olomouc 8
Osasco 8
Sorocaba 8
Thái Bình 8
Baghdad 7
Campinas 7
Chiswick 7
Goiânia 7
Johannesburg 7
Karaj 7
Medellín 7
Totale 8.481
Salva come PNG Salva come JPEG
Nome #
Cushing Syndrome: The Role of MSCs in Wound Healing, Immunosuppression, Comorbidities, and Antioxidant Imbalance 185
Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors. 158
ISOLATION AND CHARACTERIZATION OF MESENCHYMAL CELLS FROM PITUITARY TUMOURS 149
Impact of COVID-19 pandemic on psychophysical stress in patients with adrenal insufficiency: the CORTI-COVID study 148
Age-related modifications of the human growth hormone circadian secretory pattern studied with a new statistical method in healthy adults 140
Qualità della vita nei pazienti con sindrome adrenogenitale ed impatto della terapia sostitutiva. 140
Adrenal incidentaloma: surgical update. 136
Desmopressin test in the differential diagnosis of Pseudo-Cushing state from Cushing’s disease. 127
Effects of long-term treatment with human pure FSH on seminal parameters and sperm cells ultrastructure in idiopathic oligo-asthenozoospermia. 127
The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study 126
Pituitary adenomas, stem cells, and cancer stem cells: what's new? 125
ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease. 124
Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. 119
Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications. 117
Acromegaly and male sexual health 114
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome 114
Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants. 113
Importance of sleep and melatonin for the human prolactin circadian secretory pattern in normal and pathological conditions 111
Ruolo dell’osmolarità seminale nella regolazione della motilità degli spermatozoi nell’uomo 110
RNA sequencing and somatic mutation status of adrenocortical tumors: novel pathogenetic insights 110
Decreased expression of insulin-sensitive glucose transporter mRNA (GLUT-4) in adipose tissue of non-insulin-dependent diabetic and obese patients: evaluation by a simplified quantitative PCR assay. 109
The medical treatment with pasireotide in Cushing’s disease: an Italian multicentre experience based on “real-world evidence” 108
Diagnosis and complications of Cushing's syndrome: a consensus statement 107
Echo Doppler in the characterization of thyroid nodular disease 107
COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency 106
Unusual clinical manifestation of pheochromocytoma in a MEN2A patient 104
A novel endothelial tyrosine kinase cDNA homologous to platelet-derived growth factor receptor cDNA. 104
Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. 104
Analisys of Y-linked microdeletions in idiopathic oligo- and azoospermic patients 103
Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels Develop Insulin-Resistance and Altered Lipolysis: A Promising In Vitro Model to Study Cushing’s Syndrome 103
Effects of somatostatin and its analogues on progenitor mesenchymal cells isolated from human pituitary adenomas 101
Coenzyme Q10 levels in idiopathic and varicocele-associated asthenozoospermia 98
How to improve effectiveness of pegvisomant treatment in acromegalic patients 98
High-dose and high-frequency lanreotide autogel in acromegaly: A randomized, multicenter study 95
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 95
Hypothalamic-Pituitary Diseases and Erectile Dysfunction 95
Corticotropin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and Pseudo-Cushing state: a comparative study. 93
An evaluation of the ultrastructural features improvement in idiopathic oligo-astenospermia after FSH treatment 93
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype 93
Impatto della terapia sostitutiva sulla qualità della vita nei pazienti con iperplasia surrenalica congenita. 93
Self image and quality of life in acromegaly 92
ADRENAL MORPHO-FUNCTIONAL ALTERATIONS IN PATIENTS WITH ACROMEGALY. 91
Adrenal incidentaloma. 90
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome. 90
Androgens in Cushing's Syndrome 90
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion 90
Safety and effectiveness of Omnitrope® in patients with growth hormone deficiency: snapshot analysis of PATRO Adults study in the Italian population 90
Glucocorticoid excess and COVID-19 disease 90
A Single-Center 10-Year Experience with Pasireotide in Cushing's Disease: Patients' Characteristics and Outcome. 89
Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome 89
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma 89
Isolation and characterization of Mesenchymal Stem Cells from pituitary tumours 88
Determinazione comparativa dei livelli del coenzima Q10 nelle oligozoospermie idiopatiche e nel varicocele 87
ACTH receptor mRNA in human adrenocortical tumors: overexpression in aldosteronomas. 87
Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation. 87
COVID-19 and endocrine and metabolic disorders: critical points and suggestions for a correct therapeutic management from a tertiary endocrine center in Italy 87
Fine-needle aspiration cytology of adrenal masses: a re-assessment with histological confirmation. 86
Acromegaly Is More Severe in Patients With AHR or AIP Gene Variants Living in Highly Polluted Areas 86
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 86
High cardiovascular risk in patients with Cushing's syndrome accorìging to 1999 WHO/ISH guidelines 86
Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease 85
Enhanced expression of transforming growth factor beta 1 in rat thyroid hyperplasia is thyrotropin induced and time dependent 85
Pituitary adenoma apoplexy: Review of personal series. 85
Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. 85
New treatment guidelines on Cushing's disease. 83
Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group. 83
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: A multicenter study 83
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH-dependent Cushing's syndrome 83
Somatic PRKACA Mutations: Association With Transition From Pituitary-Dependent to Adrenal-Dependent Cushing Syndrome 83
Semen osmolarity and sperm motility 83
Advances in medical treatment of Cushing’s disease 81
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma 81
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours 79
The role of an acute pasireotide suppression test in predicting response to treatment in patients with Cushing’s disease: findings from a pilot study 79
Adrenal incidentaloma. 78
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial 78
Pachychoroid spectrum disease and choriocapillary flow analysis in patients with Cushing disease: an optical coherence tomography angiography study 78
Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial 77
High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. 76
Analysis of GRP101 and AIP genes mutations in acromegaly: a multicentre study 75
Acromegalia e Ancona: un fil rouge lungo trecento anni, da Amato Lusitano ad Augusto Tamburini 74
Cardiovascular risk in Cushing's syndrome. 74
Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor. 73
Intrapituitary cytokines in Cushing's disease: do they play a role? 71
AME position statement on adrenal incidentaloma. 71
Is pasireotide-induced diabetes mellitus predictable? A pilot study on the effect of a single dose of pasireotide on glucose homeostasis 71
Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas. 71
Sexual Dysfunctions in Men Affected by Autoimmune Addison's Disease Before and After Short-Term Gluco- and Mineralocorticoid Replacement Therapy 70
Functional and nonfunctional adrenocortical tumors demonstrate a high responsiveness to low-dose adrenocorticotropin. 70
Histological contamination in clinical research: from ultrastrcture to stem cel biology. 70
Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trials 69
[Cytological diagnosis of thyroid nodules. Comparison of results obtained with guided echography with those from of a "blind" biopsy]. 69
Conventional and nuclear medicine imaging in Ectopic Cushing's syndrome: A systematic review 69
Up-to 5-year efficacy of pasireotide in a patient with Cushing's disease and pre-existing diabetes: literature review and clinical practice considerations 69
Harmful effects of functional hypercortisolism: a working hypothesis. 69
Protective role of ubiquinol-10 against peroxidation in human seminal fluid plasma 69
Second-line tests in the differential diagnosis of ACTH-dependent Cushing's syndrome 68
Treatment of Plummer's adenoma: correlation between ultrasonography-guided percutaneous injection of ethanol and autoimmunity 67
Laurdan fluorescence: a simple method to evaluate spermatozoa plasma membrane alteration. 67
A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. 67
Totale 9.390
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.440
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.169 0 0 0 0 0 93 227 183 218 148 200 100
2021/20221.137 60 225 29 68 7 77 41 90 80 101 101 258
2022/20232.311 210 232 165 174 108 609 6 103 525 11 120 48
2023/20241.356 236 45 120 178 214 272 38 31 7 40 20 155
2024/20252.336 321 223 81 26 65 56 282 91 521 179 228 263
2025/20262.969 408 523 405 791 682 160 0 0 0 0 0 0
Totale 13.511